CIK 0001636651 · Non-accelerated filer<br>Smaller reporting company
Ovid Therapeutics Inc.
Sign in to watch- Ticker
- OVID
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 465270895
- Phone
- 212-776-4381
- Business address
- 441 NINTH AVENUE, 14TH FLOOR, NEW YORK, NY, 10001
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 8-K Event Shareholder vote results
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 8-K Event Other events
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- ARS Other Annual Report to Security Holders
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Director nominations
- PRE 14A Proxy Proxy Statement (Preliminary)
- 10-K/A Report 10-K/A
- 10-K Report Annual Report
- 8-K Event Results of operations
- 8-K Event Executive or director change
- 4 Insider Changes in Ownership
Page 5 of 27 · 535 filings